No impact to previous guidance.In some ways this is positive as Phase 3 trials cost a lot to run.Csl can concentrate on making the AstraZeneca/Oxford vaccine instead.
- Forums
- ASX - By Stock
- CSL
- Ann: Update on UQ-CSL v451 COVID-19 Vaccine
Ann: Update on UQ-CSL v451 COVID-19 Vaccine, page-2
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$276.36 |
Change
1.355(0.49%) |
Mkt cap ! $133.5B |
Open | High | Low | Value | Volume |
$274.45 | $276.83 | $274.30 | $44.91M | 162.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $276.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$276.36 | 40 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 120 | 276.400 |
4 | 53 | 276.390 |
1 | 1 | 276.380 |
5 | 56 | 276.370 |
2 | 31 | 276.360 |
Price($) | Vol. | No. |
---|---|---|
276.410 | 7 | 1 |
276.420 | 8 | 2 |
276.430 | 25 | 5 |
276.440 | 21 | 3 |
276.450 | 12 | 1 |
Last trade - 14.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
Last
$276.30 |
  |
Change
1.355 ( 0.46 %) |
|||
Open | High | Low | Volume | ||
$274.92 | $276.81 | $274.81 | 17567 | ||
Last updated 14.27pm 30/04/2024 ? |
Featured News
CSL (ASX) Chart |